1. Academic Validation
  2. Aβ-42 lowering agents from the marine-derived fungus Dichotomomyces cejpii

Aβ-42 lowering agents from the marine-derived fungus Dichotomomyces cejpii

  • Steroids. 2015 Dec;104:182-8. doi: 10.1016/j.steroids.2015.09.012.
Henrik Harms 1 Stefan Kehraus 1 Damun Nesaei-Mosaferan 1 Peter Hufendieck 1 Laurent Meijer 2 Gabriele M König 3
Affiliations

Affiliations

  • 1 Institute for Pharmaceutical Biology, University of Bonn, 53115 Bonn, Germany.
  • 2 ManRos Therapeutics, Centre de Perharidy, 29680 Roscoff, France.
  • 3 Institute for Pharmaceutical Biology, University of Bonn, 53115 Bonn, Germany. Electronic address: g.koenig@uni-bonn.de.
Abstract

The ascomycete Dichotomomyces cejpii was isolated from the marine Sponge Callyspongia cf. C. flammea. Three new Steroids (1-3), two of which are present as glycosides, with an untypical pattern of carbon-carbon double bounds, were obtained from Fungal extracts, as well as the known xanthocillin X dimethyl ether (4). Compounds 2 and 4 were evaluated in an Alzheimer's disease cellular assay and found capable of preventing the enhanced production of amyloid β-42 in Aftin-5 treated cells. Aβ-42 lowering agents are considered as candidates for the treatment of neurodegenerative Alzheimer's disease.

Keywords

Alzheimer’s disease; Dichotomomyces cejpii; Ergosterol derivatives.

Figures
Products